Sex-hormone receptors pattern on regulatory T-cells: Clinical implications for multiple sclerosis

Clinical and Experimental Medicine

Volumn 12, Issue 4, 2012, Pages 247-255

  Aristimuño, Carol ^a   Teijeiro, Roseta ^a   Valor, Lara ^a   Alonso, Bárbara ^a   Tejera Alhambra, Marta ^a   De Andrés, Clara ^a   Miñarro, Desamparados Oliver ^a   López Lazareno, Nieves ^a   Faure, Florence ^b   Sánchez Ramón, Silvia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

Multiple sclerosis; Oestradiol receptors; Regulatory T cells; Sex hormones

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; PROGESTERONE; PROGESTERONE RECEPTOR; TESTOSTERONE;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MALE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TESTOSTERONE BLOOD LEVEL;

ESTRADIOL; ESTROGEN RECEPTOR BETA; HORMONES; HUMANS; MALE; MULTIPLE SCLEROSIS; PROGESTERONE; T-LYMPHOCYTES, REGULATORY;

EID: 84870449949     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0172-3     Document Type: Article

References (64)

1. Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11: 411-423 (Pubitemid 40895468)
2. De Andre's C, Rodriguez-Sainz MC, Munoz-Fernandez MA, Lopez-Lazareno N, Rodriguez-Mahou M, Vicente A, Ferna'ndez-Cruz E, Sa'nchez-Ramo'n S (2004) Short-term sequential analysis of sex hormones and helper T cells type 1 (Th1) and helper T cells type 2 (Th2) cytokines during and after multiple sclerosis relapse. Eur Cytokine Netw 15:197-202 (Pubitemid 39389915)
3. Whitacre CC, Reingold SC, O'Looney PA (1999) A gender gap in autoimmunity. Science 283:1277-1278 (Pubitemid 129507205)
4. Whitaker JN (1998) Effects of pregnancy and delivery on disease activity in multiple sclerosis. N Engl J Med 339:339-340 (Pubitemid 28366424)
5. Gourdy P, Araujo LM, Zhu R, Garmy-Susini B, Diem S, Laurell H et al (2005) Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-{c} production by invariant natural killer T cells. Blood 105:2415-2420 (Pubitemid 40387040)
6. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med 339:285-291 (Pubitemid 28366416)
7. Confavreux C, Hutchinson M, Hours M, Cortinovis-Tourniaire P, Grimaud J, Moreau T (1999) Multiple sclerosis and pregnancy: clinical issues. Rev Neurol (Paris) 155:186-191 (Pubitemid 29200361)
8. Salemi G, Callari G, Gammino M, Battaglieri F, Cammarata E, Cuccia G et al (2004) The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand 110:23-26 (Pubitemid 38850552)
9. Dwosh E, Guimond C, Duquette P, Sadovnick AD (2003) The interaction of MS and pregnancy: a critical review. Int MS J 10:38-42 (Pubitemid 36717789)
10. Sa'nchez-Ramo'n S, Navarro J, Aristimuno C, Rodriguez-Mahou M, Bellon JM, Fernandez-Cruz E, de Andre's C (2005) Pregnancyinduced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol Lett 96:195-201 (Pubitemid 39600775)
11. Tulchinsky D, Hobel CH, Yeager E, Marshall JR (1972) Plasma estrone, estradiol, estriol, progesterone and 17-hydroxyprogesterone in human pregnancy: I. Normal pregnancy. Am J Obstet Gynecol 112:1095-1100
12. Baecher-Allan C, Viglietta V, Hafler DA (2004) Human CD4+CD25+ regulatory T cells. Semin Immunol 16:89-98
13. Bach JF, Bach JF (2003) Regulatory T cells under scrutiny. Nat Rev Immunol 3:189-198 (Pubitemid 37323204)
14. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD et al (2001) Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 98:2736-2744
15. Vlad G, Cortesini R, Suciu-Foca N (2005) License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 174:5907-5914 (Pubitemid 40663774)
16. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor foxp3. Science 299: 1057-1061 (Pubitemid 36222930)
17. Sakaguchi S (2005) Naturally arising foxp3-expressing CD25?CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345-352 (Pubitemid 41716771)
18. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat immunol 3:135-142 (Pubitemid 34141443)
19. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+ CD25high regulatory cells in human peripheral blood. J Immunol 167:1245-1253 (Pubitemid 32703119)
20. Stephens LA, Mottet C, Mason D, Powrie F (2001) Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31:1247-1254
21. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G (2001) Ex vivo isolation and characterization of CD4(+) CD25(+) T cells with regulatory properties from human blood. J Exp Med 193:1303-1310 (Pubitemid 32524780)
22. Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287-296 (Pubitemid 28357757)
23. Taams LS, Vukmanovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, Plunkett FJ et al (2002) Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 32:1621-1630 (Pubitemid 34679150)
24. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971-979 (Pubitemid 38481088)
25. Kolkova Z, Noskova V, Ehinger A, Hansson S, Casslen B (2010) G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua. Mol Hum Reprod 16:743-751
26. Polanczyk M, Zamora A, Subramanian S, Matejuk A, Hess DL, Blankenhorn EP et al (2003) The protective effect of 17betaestradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha.AmJ Pathol 163:1599-1605 (Pubitemid 37175106)
27. Scariano JK, Emery-Cohen AJ, Pickett GG, Morgan M, Simons PC, Alba F (2008) Estrogen receptors alpha (ESR1) and beta (ESR2) are expressed in circulating human lymphocytes. J Recept Signal Transduct Res 28:285-293 (Pubitemid 351882219)
28. Giraud SN, Caron CM, Pham-Dinh D, Kitabgi P, Nicot AB (2010) Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappab-dependent ccl2 expression in reactive astrocytes. Proc Natl Acad Sci USA 107:8416-8421
29. Yates MA, Li Y, Chlebeck P, Proctor T, Vandenbark AA, Offner H (2010) Progesterone treatment reduces disease severity and increases il-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol 220:136-139
30. Poser CM, Paty DW, Scheinberg L, Mcdonald WI, Davis FA, Ebers GC et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231 (Pubitemid 13158528)
31. Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452 (Pubitemid 14237132)
32. Aristimuño C, Navarro J, Faure F, De Andrés C, Rodríguez-Mahou M, López-Lazareno N, Gil J, Roncador G, Fernández-Cruz E, Sánchez-Ramón S (2006) Unique differential expression of sex hormones receptors by regulatory T lymphocytes may explain low suppressive activity in multiple sclerosis. Mult Scler 11:S128
33. De Andres C, Aristimuno C, Bartolome M, De Las Heras V, Martinez-Gines ML, Arroyo R et al (2009) Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells differential role of circulating dendritic cells and CD4(+) regulatory T-cells in relapsingremitting multiple sclerosis: a 1-year longitudinal study. J Neuroimmunol 212:112-120
34. De Andres C, Aristimuno C, De Las Heras V, Martinez-Gines ML, Bartolome M, Arroyo R et al (2007) Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J Neuroimmunol 182:204-211 (Pubitemid 46026708)
35. Resino S, Sanchez-Ramon S, Bellon JM, Correa R, Abad ML, Munoz-Fernandez MA (2002) Immunological recovery after 3 years' antiretroviral therapy in HIV-1-infected children. Aids 16:483-486 (Pubitemid 34165382)
36. Peck JD, Hulka B, Poole C, Savitz DA, Baird D, Richardson B (2002) Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 11:361-368 (Pubitemid 34408215)
37. Wells AD, Gudmundsdottir H, Turka LA (1997) Following the fate of individual T cells throughout activation and clonal expansion. J Clin Invest 100:3173-3183
38. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF et al (2004) Cutting edge: Estrogen drives expansion of the CD4 + CD25 + regulatory T cell compartment. J Immunol 173:2227-2230 (Pubitemid 39063075)
39. Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A et al (2009) 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57:807-814
40. Prieto GA, Rosenstein Y (2006) Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 118:58-65
41. Valor L, Teijeiro R, Aristimuño C, Faure F, Alonso B, de Andre's C, Tejera M, Lo'pez-Lazareno N, Ferna'ndez-Cruz E, Sa'nchez-Ramo'n S (2011) Estradiol-dependent perforin expression by human regulatory T-cells. Eur J Clin Invest 41:357-364
42. Levin ER (2002) Cellular functions of plasma membrane estrogen receptors. Steroids 67:471-475 (Pubitemid 34311762)
43. Garidou L, Laffont S, Douin-Echinard V, Coureau C, Krust A, Chambon P et al (2004) Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiolmediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 173:2435-2442 (Pubitemid 39063100)
44. Whitacre CC (2001) Sex differences in autoimmune disease. Nat Immunol 2:777-780
45. Pedram A, Razandi M, Kim JK, O'Mahony F, Lee EY, Luderer U et al (2009) Developmental phenotype of a membrane only estrogen receptor alpha (moer) mouse. J Biol Chem 284: 3488-3495
46. Pedram A, Razandi M, Levin ER (2006) Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20:1996-2009 (Pubitemid 44286700)
47. Adori M, Kiss E, Barad Z, Barabas K, Kiszely E, Schneider A et al (2010) Estrogen augments the T cell-dependent but not the T-independent immune response. Cell Mol Life Sci 67: 1661-1674
48. Nadal A, Rovira JM, Laribi O, Leon-Quinto T, Andreu E, Ripoll C et al (1998) Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor. Faseb J 12:1341-1348 (Pubitemid 28475575)
49. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER (2004) Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18:2854-2865 (Pubitemid 39577911)
50. Razandi M, Pedram A, Levin ER (2010) Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane. Mol Cell Biol 30(13):3249-3261
51. Tiwari-Woodruff S, Morales LB, Lee R, Voskuhl RR (2007) Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)a and ERb ligand treatment. Proc Natl Acad Sci USA 104:14813-14818 (Pubitemid 350003225)
52. Tomassini V, Onesti E, Mainero C, Giugni E, Paolillo A, Salvetti M et al (2005) Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 76: 272-275 (Pubitemid 40143725)
53. Navarro J, Aristimuno C, Sanchez-Ramon S, Vigil D, Martinez-Gines Ml, Fernandez-Cruz E, Sa'nchez-Ramo'n S (2006) Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy. J Neuroimmunol 176:153-161 (Pubitemid 44088664)
54. Bansil S, Lee HJ, Jindal S, Holtz CR, Cook SD (1999) Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand 99:91-94 (Pubitemid 29064313)
55. Pozzilli C, Falaschi P, Mainero C, Martocchia A, D'Urso R, Proietti A et al (1999) MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology 53:622-624 (Pubitemid 29382062)
56. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S et al (2002) Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52:421-428
57. Piccinni MP, Romagnani S (1996) Regulation of fetal allograft survival by a hormone-controlled th1-and th2-type cytokines. Immunol Res 15:141-150 (Pubitemid 26232480)
58. Szekeres-Bartho J, Par G, Szereday L, Smart CY, Achatz I (1997) Progesterone and non-specific immunologic mechanisms in pregnancy. Am J Reprod Immunol 38:176-182 (Pubitemid 27379528)
59. Laskarin G, Strbo N, Sotosek V, Rukavina D, Faust Z, Szekeres-Bartho J et al (1999) Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am J Reprod Immunol 42:312-320 (Pubitemid 29502164)
60. Szekeres-bartho J, Polgar B, Kozma N, Miko E, Par G, Szereday L et al (2005) Progesterone-dependent immunomodulation. Chem Immunol Allergy 89:118-125 (Pubitemid 43154890)
61. Matejuk A, Bakke AC, Hopke C, Dwyer J, Vandenbark AA, Offner H (2004) Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. J Neurosci Res 77:119-126 (Pubitemid 38850062)
62. Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR (2003) Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol 171:6267-6274 (Pubitemid 37467250)
63. Voskuhl RR, Palaszynski K (2001) Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7:258-270 (Pubitemid 32489119)
64. Walker Mr, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH et al (2003) Induction of foxp3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 112:1437-1443 (Pubitemid 38057697)